From: Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes
Total number
Irregular
Multilayer
CUR@L
200
1 (0.05%)
2 (0.1%)
CUR-PTX@PEG-L
300
0
5 (1.6%)
CUR-PTX @ GE 11-L
6 (2%)